Product Information
NEUPOGEN 300 MCG/ML VIAL is a brand product labeled by Amgen Inc., priced at $304.3070 per ML under NDC 55513053010. Its NADAC has been published 253 times since Nov 28, 2013.
Strength
300 ug/mL
Manufacturer
Amgen Inc.NDC
55513053010
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
FILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA103353On Market Since
5/19/1997
Pharmacological Classes
Price Statistics
The NADAC for NEUPOGEN 300 MCG/ML VIAL has been published 253 times since Nov 28, 2013, and over the history we have for it it has risen 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $304.3070 per ML |
|---|---|
| All-time high | $306.6472 (Jan 14, 2026) |
| All-time low | $278.5910 (Jun 18, 2014) |
| 52-week high | $306.6472 |
| 52-week low | $303.7760 |
| Median price | $291.3080 |
| Average price | $295.4624 |
| Largest weekly change | +4.6% (Apr 17, 2024) |
| Weeks tracked | 253 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NEUPOGEN 300 MCG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for NEUPOGEN 300 MCG/ML VIAL, manufactured by Amgen Inc., is $304.3070 per ML (NDC 55513053010), effective Jun 24, 2026.
How has the price of NEUPOGEN 300 MCG/ML VIAL changed over time?
Over the history we have for it, the NADAC for NEUPOGEN 300 MCG/ML VIAL has risen 6.7%. It has been tracked across 253 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEUPOGEN 300 MCG/ML VIAL?
Since Nov 28, 2013, the NADAC for NEUPOGEN 300 MCG/ML VIAL has ranged from a low of $278.5910 (Jun 18, 2014) to a high of $306.6472 (Jan 14, 2026), with a median of $291.3080 per ML.
Are there cheaper alternatives to NEUPOGEN 300 MCG/ML VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as NEUPOGEN 300 MCG/ML VIAL, but none are currently priced below it.
Who manufactures NEUPOGEN 300 MCG/ML VIAL?
NEUPOGEN 300 MCG/ML VIAL (NDC 55513053010) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification